Literature DB >> 1723263

Ki-67 as a marker for cell cycle regulation by interferon.

D Lundblad1, G Landberg, G Roos, E Lundgren.   

Abstract

The effects of interferon (IFN) on the expression of the nuclear antigen Ki-67 were studied in the two IFN-sensitive tumour cell lines Daudi and 251 MG, known to be arrested in the cell cycle in separate stages. The GO/G1-arrested Burkitt's lymphoma cell line Daudi displayed an increasing fraction of Ki-67 negative cells with time, concomitant with an increasing proportion of growth arrested cells. A small fraction of Ki-67 positive cells were found mainly arrested in G2/M. In contrast, no effect on Ki-67 expression was seen in IFN-resistant Namalwa cells, nor in the sensitive glioma cell line 251 MG, which is blocked in the S phase of the cell cycle. Agents blocking the cells in other phases of the cycle did not affect Ki-67 expression. However, after serum deprivation, no Ki-67 expression was found in the glioma cell line, while restimulation initiated expression after 12 hours as cells entered the S phase. We conclude that the Ki-67 antigen was not down regulated in all cells inhibited by IFN and thus does not seem to be useful to monitor clinical effects of IFN treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723263

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  The Cytolethal Distending Toxin Subunit CdtB of Helicobacter hepaticus Promotes Senescence and Endoreplication in Xenograft Mouse Models of Hepatic and Intestinal Cell Lines.

Authors:  Christelle Péré-Védrenne; Martina Prochazkova-Carlotti; Benoit Rousseau; Wencan He; Lucie Chambonnier; Elodie Sifré; Alice Buissonnière; Pierre Dubus; Francis Mégraud; Christine Varon; Armelle Ménard
Journal:  Front Cell Infect Microbiol       Date:  2017-06-30       Impact factor: 5.293

2.  Cytolethal distending toxin induces the formation of transient messenger-rich ribonucleoprotein nuclear invaginations in surviving cells.

Authors:  Lamia Azzi-Martin; Wencan He; Christelle Péré-Védrenne; Victoria Korolik; Chloé Alix; Martina Prochazkova-Carlotti; Jean-Luc Morel; Emilie Le Roux-Goglin; Philippe Lehours; Mojgan Djavaheri-Mergny; Christophe F Grosset; Christine Varon; Pierre Dubus; Armelle Ménard
Journal:  PLoS Pathog       Date:  2019-09-30       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.